Oral remdesivir derivative VV116 is a potent inhibitor of respiratory syncytial virus with efficacy in mouse model
文献类型:期刊论文
作者 | Zhang, Ruxue2,3; Zhang, Yumin2; Zheng, Wei1,3; Shang, Weijuan2; Wu, Yan2; Li, Ning4; Xiong, Jun4; Jiang, Hualiang1,3![]() |
刊名 | SIGNAL TRANSDUCTION AND TARGETED THERAPY
![]() |
出版日期 | 2022-04-16 |
卷号 | 7期号:1页码:3 |
ISSN号 | 2095-9907 |
DOI | 10.1038/s41392-022-00963-7 |
通讯作者 | Xie, Yuanchao(xieyuanchao@simm.ac.cn) ; Zhang, Leike(zhangleike@wh.iov.cn) |
WOS关键词 | DISCOVERY |
资助项目 | National Natural Science Foundation of China[31970165] ; National Key Research and Development Program of China[2021YFC2300700] ; Shanghai Municipal Science and Technology Major Project ; Youth Innovation Promotion Association CAS[2018367] |
WOS研究方向 | Biochemistry & Molecular Biology ; Cell Biology |
语种 | 英语 |
WOS记录号 | WOS:000782897800001 |
出版者 | SPRINGERNATURE |
源URL | [http://119.78.100.183/handle/2S10ELR8/299794] ![]() |
专题 | 中国科学院上海药物研究所 |
通讯作者 | Xie, Yuanchao; Zhang, Leike |
作者单位 | 1.Chinese Acad Sci, Shanghai Inst Mat Med, Shanghai 201203, Peoples R China 2.Chinese Acad Sci, Wuhan Inst Virol, State Key Lab Virol, Ctr Biosafety Mega Sci, Wuhan 430071, Peoples R China 3.Univ Chinese Acad Sci, Beijing 100049, Peoples R China 4.Shanghai Junshi Biosci Co Ltd, Shanghai 200126, Peoples R China 5.Lingang Lab, Shanghai 200031, Peoples R China |
推荐引用方式 GB/T 7714 | Zhang, Ruxue,Zhang, Yumin,Zheng, Wei,et al. Oral remdesivir derivative VV116 is a potent inhibitor of respiratory syncytial virus with efficacy in mouse model[J]. SIGNAL TRANSDUCTION AND TARGETED THERAPY,2022,7(1):3. |
APA | Zhang, Ruxue.,Zhang, Yumin.,Zheng, Wei.,Shang, Weijuan.,Wu, Yan.,...&Zhang, Leike.(2022).Oral remdesivir derivative VV116 is a potent inhibitor of respiratory syncytial virus with efficacy in mouse model.SIGNAL TRANSDUCTION AND TARGETED THERAPY,7(1),3. |
MLA | Zhang, Ruxue,et al."Oral remdesivir derivative VV116 is a potent inhibitor of respiratory syncytial virus with efficacy in mouse model".SIGNAL TRANSDUCTION AND TARGETED THERAPY 7.1(2022):3. |
入库方式: OAI收割
来源:上海药物研究所
浏览0
下载0
收藏0
其他版本
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。